3P;+;R5NP/7,=,J_BGTY/8X/9.]HGX;3TL5S?3AO0W(}N/&
SYSTEM PROCESSING...
3P;+;R5NP/7,=,J_BGTY/8X/9.]HGX;3TL5S?3AO0W(}N/&
SYSTEM PROCESSING...
Posted: 2025-04-25 20:01:16 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-25 20:01:52 UTC
Verified By
Rollup News
A federal judge has ruled against compounding pharmacies producing copycat versions of Ozempic and Wegovy, citing the FDA's declaration that there is no longer a shortage of semaglutide.
Compounding pharmacies are barred from producing Ozempic and Wegovy knockoffs.
The FDA's assessment of no semaglutide shortage influenced the court's decision.
Larger compounders have until May 22 to cease production, while smaller ones must stop immediately.
Compounding pharmacies attempting to produce Ozempic and Wegovy copies.
Legal battle over semaglutide shortages.
FDA's assessment influencing the court's decision.